Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer
Alfredo Berruti(University of Brescia), Martin Faßnacht(München Klinik), Harm R. Haak(Radboud University Nijmegen), Tobias Else(Michigan Medicine), Éric Baudin, Paola Sperone(University of Turin), Matthias Kroiß(Universitätsklinikum Würzburg), Thomas Kerkhofs(Máxima Medisch Centrum), Andrew Williams(Michigan Medicine), Arianna Ardito(Ospedale San Luigi Gonzaga), Sophie Leboulleux, Marco Volante(University of Turin), Timo Deutschbein(Universitätsklinikum Würzburg), Richards Feelders(Erasmus MC), Cristina L. Ronchi(Universitätsklinikum Würzburg), Salvatore Grisanti(University of Brescia), Hans Gelderblom(Leiden University Medical Center), F. Porpiglia(Ospedale San Luigi Gonzaga), Mauro Papotti(University of Turin), Gary D. Hammer(Michigan Medicine), Bruno Allolio(Universitätsklinikum Würzburg), Massimo Terzolo(Ospedale San Luigi Gonzaga)
Cited by 151Open Access
Abstract
Related Papers
Clinical and Biological Features in the Prognosis of Adrenocortical Cancer: Poor Outcome of Cortisol-Secreting Tumors in a Series of 202 Consecutive Patients
G. Abiven, Joël Coste, Lionel Groussin et al.|The Journal of Clinical Endocrinology & Metabolism|2006|437